Insider Brief
- QMatter raised $1.2 million in pre-seed funding led by 55 North to advance its quantum compression platform aimed at making complex simulations more tractable.
- The company’s technology reduces the size of quantum problems before computation, enabling both classical and near-term quantum systems to handle simulations that are currently beyond reach.
- QMatter is targeting life sciences applications, particularly drug discovery and materials research, while also generating physics-informed datasets to support next-generation AI model training.
- Image: QMatter co-founders (l-r) Timothy Weaving and Alexis Ralli.
PRESS RELEASE — Quantum technology startup QMatter has raised $1.2M in pre-seed funding, led by 55 North, the world’s largest pure-play quantum fund, with participation from XTX Ventures, Bellstate Oy and the Conception X Angel Syndicate. The company will use the capital to further develop and scale its quantum compression platform.
Simulating quantum mechanics is extremely computationally demanding, and current computers, both classical and quantum, cannot handle the most complex challenges in drug discovery and materials science.
QMatter’s current focus is the life sciences market, working with pharmaceutical and biotechnology companies to accelerate R&D by enabling better simulation data and ultimately improving research outcomes. In parallel, the company is generating high‑quality, physics‑informed data libraries, creating new opportunities for machine learning companies to train next‑generation AI models using previously unavailable, problem‑specific data.
Quantum computers, which process information using quantum mechanical principles, are theoretically well-suited to these simulations. But despite rapid hardware progress, a fundamental limitation remains: today’s systems cannot reliably scale to industrially relevant problem sizes. Quantum devices have limited qubit counts, while noise and instability reduce the number of usable qubits further. As a result, the most commercially valuable simulations remain out of reach.
QMatter’s quantum compression technology applies principles from quantum mechanics to reduce the size of a problem before it is run on a quantum or classical system. The approach is designed to extend what current, near-term and future quantum computers can handle, while also accelerating classical algorithms at every scale, from consumer hardware to large supercomputers. This dual approach positions QMatter at the forefront of algorithms design, where previously intractable problems are reduced to a size where solutions become possible today.
Alexis Ralli, Co-founder & CEO, QMatter: “QMatter compresses complex quantum problems to their essential core, ensuring solutions remain both accurate and useful. By doing so, we unlock greater performance from today’s quantum hardware while broadening the problem landscape for future error-corrected machines.”
Tim Weaving, Co-founder & CTO, QMatter: “Quantum computing promises to be transformational for the hardest problems we face, but the full value remains unrealized due to real-world limitations that constrain the size of problems we can address today. This investment will support the continued development of our quantum compression platform.”
QMatter was founded in 2024 by Dr. Alexis Ralli and Dr. Timothy Weaving, who obtained their PhDs in quantum computing and molecular modelling from University College London, alongside Prof. Peter Coveney (University College London) and Prof. Peter Love (Tufts University). The founding team has backgrounds in quantum computing and high-performance computing, with a focus on life science applications.
Helmut Katzgraber, CSO & General Partner, 55 North: “The first commercially valuable applications of quantum computing devices will likely be in chemistry and pharmaceuticals. QMatter’s compression approach accelerates the timelines and brings these applications closer to the market.”
